These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35136158)

  • 41. Serum leptin levels in rheumatoid arthritis and relationship with disease activity.
    Gunaydin R; Kaya T; Atay A; Olmez N; Hur A; Koseoglu M
    South Med J; 2006 Oct; 99(10):1078-83. PubMed ID: 17100028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of disease activity indices in Korean patients with rheumatoid arthritis.
    Park SY; Lee H; Cho SK; Choi CB; Sung YK; Bae SC
    Rheumatol Int; 2012 Feb; 32(2):545-9. PubMed ID: 21305296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
    Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
    Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Red blood cell distribution width-to-platelet ratio inversely correlates with indicators of disease activity status in rheumatoid arthritis patients.
    Dervišević A; Muhić A; Začiragić A; Fajkić A; Dervišević L; Hasanbegović I; Lepara O; Galijašević M
    Rom J Intern Med; 2021 Jun; 59(2):180-186. PubMed ID: 33565306
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation of the Multi-Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis.
    Johnson TM; Register KA; Schmidt CM; O'Dell JR; Mikuls TR; Michaud K; England BR
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1459-1472. PubMed ID: 30320973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study.
    Johnson J; Yeter K; Rajbhandary R; Neal R; Tian Q; Jian J; Fadle N; Thurner L; Liu C; Stohl W
    Clin Rheumatol; 2017 Mar; 36(3):507-516. PubMed ID: 27830341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.
    Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner S; Stein CM
    Arthritis Res Ther; 2013; 15(5):R110. PubMed ID: 24020899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective factors on Sharp Score in patients with rheumatoid arthritis: a retrospective study.
    Wen J; Liu J; Xin L; Wan L; Jiang H; Sun Y; Sun Y; Wang X; Wang J
    BMC Musculoskelet Disord; 2021 Oct; 22(1):865. PubMed ID: 34627206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms.
    Li P; Yang L; Ma CL; Liu B; Zhang X; Ding R; Bi LQ
    Clin Rheumatol; 2015 Jun; 34(6):1025-30. PubMed ID: 25750183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical significance of detection of soluble interleukin 2 receptor alpha chain in the assessment of rheumatoid arthritis disease activity].
    Xu JJ; Wang Y; Sun H; Jia RL; Zhang XW; Meng Y; Ren LL; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):975-980. PubMed ID: 30562767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab.
    Tuckwell K; Gabay C; Sornasse T; Laubender RP; Wang J; Townsend MJ
    Adv Rheumatol; 2019 Dec; 59(1):54. PubMed ID: 31801637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.
    Fioravanti A; Tenti S; Bacarelli MR; Damiani A; Li Gobbi F; Bandinelli F; Cheleschi S; Galeazzi M; Benucci M
    Clin Exp Rheumatol; 2019; 37(2):293-300. PubMed ID: 30148441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
    Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
    Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic Disorders in Rheumatoid Arthritis Patients.
    Targońska-Stępniak B; Grzechnik K
    J Inflamm Res; 2022; 15():5845-5855. PubMed ID: 36247076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis.
    Ristić GG; Subota V; Stanisavljević D; Vojvodić D; Ristić AD; Glišić B; Petronijević M; Stefanović DZ
    Arthritis Res Ther; 2021 Mar; 23(1):95. PubMed ID: 33771189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
    Radovits BJ; Fransen J; van Riel PL; Laan RF
    Ann Rheum Dis; 2008 Aug; 67(8):1127-31. PubMed ID: 17965425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of human immunodeficiency virus infection on disease activity in rheumatoid arthritis: a retrospective study in South Africans.
    Tarr G; Makda M; Musenge E; Tikly M
    J Rheumatol; 2014 Aug; 41(8):1645-9. PubMed ID: 25028384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.
    Kim HR; Kim KW; Yoon SY; Kim SH; Lee SH
    J Korean Med Sci; 2010 Mar; 25(3):348-52. PubMed ID: 20191031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis?
    Castrejón I; Ortiz AM; García-Vicuña R; Lopez-Bote JP; Humbría A; Carmona L; Gonzalez-Alvaro I
    Clin Exp Rheumatol; 2008; 26(5):769-75. PubMed ID: 19032807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.